trastuzumab-pkrb 150 MG Injection

RxCUI: 2169359
RxNorm name: trastuzumab-pkrb 150 MG Injection
Display name: trastuzumab-pkrb 150 MG Injection
Full name: trastuzumab-pkrb 150 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:15

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761091	Herzuma	trastuzumab-pkrb	351(k) Biosimilar	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
HERZUMA	TRASTUZUMAB	Cephalon, Inc.	ae71c003-883a-4cd8-ad50-e8cc9a54e971	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2169359

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ae71c003-883a-4cd8-ad50-e8cc9a54e971	trastuzumab-pkrb 150 MG Injection [PSN] · trastuzumab-pkrb 150 MG Injection [SCD]	2	14	These highlights do not include all the information needed to use HERZUMA safely and effectively. See full prescribing information for HERZUMA. HERZUMA ® (trastuzumab-pkrb) for injection, for intravenous use Initial U.S. Approval: 2018 HERZUMA (trastuzumab-pkrb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222